FI963054A - Menetelmä HIV-proteaasi-inhibiittoreiden valmistamiseksi - Google Patents

Menetelmä HIV-proteaasi-inhibiittoreiden valmistamiseksi Download PDF

Info

Publication number
FI963054A
FI963054A FI963054A FI963054A FI963054A FI 963054 A FI963054 A FI 963054A FI 963054 A FI963054 A FI 963054A FI 963054 A FI963054 A FI 963054A FI 963054 A FI963054 A FI 963054A
Authority
FI
Finland
Prior art keywords
preparation
hiv protease
piperazine
protease inhibitors
optically pure
Prior art date
Application number
FI963054A
Other languages
English (en)
Swedish (sv)
Other versions
FI112218B (fi
FI963054A0 (fi
Inventor
Kai Rossen
David Askin
Paul Reider
Richard Varsolona
Ralph Volante
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI963054A0 publication Critical patent/FI963054A0/fi
Publication of FI963054A publication Critical patent/FI963054A/fi
Application granted granted Critical
Publication of FI112218B publication Critical patent/FI112218B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Catalysts (AREA)
FI963054A 1994-02-04 1996-08-01 Menetelmä optisesti puhtaan tai rikastetun piperatsiini-2-tert-butyylikarboksiamidisubstraatin valmistamiseksi FI112218B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19291694A 1994-02-04 1994-02-04
US19291694 1994-02-04
US9501232 1995-01-30
PCT/US1995/001232 WO1995021162A1 (en) 1994-02-04 1995-01-30 Process for making hiv protease inhibitors

Publications (3)

Publication Number Publication Date
FI963054A0 FI963054A0 (fi) 1996-08-01
FI963054A true FI963054A (fi) 1996-08-01
FI112218B FI112218B (fi) 2003-11-14

Family

ID=22711555

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963054A FI112218B (fi) 1994-02-04 1996-08-01 Menetelmä optisesti puhtaan tai rikastetun piperatsiini-2-tert-butyylikarboksiamidisubstraatin valmistamiseksi

Country Status (20)

Country Link
US (1) US5663341A (fi)
EP (1) EP0741712B1 (fi)
JP (1) JPH09508628A (fi)
KR (1) KR100337579B1 (fi)
AT (1) ATE206407T1 (fi)
AU (1) AU691878B2 (fi)
BR (1) BR9506727A (fi)
CA (1) CA2180947A1 (fi)
CZ (1) CZ291774B6 (fi)
DE (1) DE69523038T2 (fi)
ES (1) ES2161863T3 (fi)
FI (1) FI112218B (fi)
HU (1) HUT76303A (fi)
NZ (1) NZ279734A (fi)
RO (1) RO118292B1 (fi)
RU (1) RU2135482C1 (fi)
SK (1) SK281861B6 (fi)
TW (1) TW472047B (fi)
UA (1) UA46730C2 (fi)
WO (1) WO1995021162A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110255A (en) * 1993-07-16 1998-12-06 Merck & Co Inc Creation and resolution of 2 tert-butylcarboxamidopiprazine
US5464788A (en) * 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
KR100389151B1 (ko) * 1994-04-22 2003-10-04 고에이 가가쿠 고교 가부시키가이샤 광학활성N-tert-부틸-2-피페라진카르복시아미드의제조방법및그라세미화법
EP0710652B1 (en) * 1994-11-04 1998-03-04 Yamakawa Chemical Industry Co., Ltd. Process for preparing optically active piperazine derivatives and intermediates for preparation
ES2181865T3 (es) * 1995-01-23 2003-03-01 Lonza Ag Procedimiento para preparar amidas de acido 1,4,5,6, tetrahidro-pirazina-2-carboxilico.
US5618937A (en) * 1995-03-15 1997-04-08 Merck & Co., Inc. Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide
US5612484A (en) * 1995-05-18 1997-03-18 Merck & Co., Inc. Process for making HIV protease inhibitors
DE19536658C2 (de) * 1995-09-30 1998-02-19 Degussa Verfahren zur kontinuierlichen Herstellung von basischen, cyclischen, optisch aktiven alpha-Aminosäuren
CA2201218C (en) * 1996-04-23 2004-09-28 Rudolf Fuchs Process for the preparation of optically active piperazine-2-carboxylic acid derivatives
US8404690B2 (en) 2003-02-14 2013-03-26 Merck Serono Sa Piperazine-2-carboxamide derivatives
GB0314260D0 (en) 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB604185A (en) * 1940-08-08 1948-06-30 Arthur Mandl Improvements in electric rectifier systems used in power or control systems such as for follow-up systems
US3692775A (en) * 1969-03-17 1972-09-19 Allied Chem Racemization of d-or l-{60 -amino-caprolactam in the presence of metal ions
US3852351A (en) * 1972-10-02 1974-12-03 Fmc Corp Chlorination of acetoacetamides
JPH01117869A (ja) * 1987-10-30 1989-05-10 Hokuriku Seiyaku Co Ltd ２−アミノメチルピペラジン誘導体
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
CA2081970C (en) * 1991-11-08 1997-07-08 Joseph P. Vacca Hiv protease inhibitors useful for the treatment of aids
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
MX9308016A (es) * 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.

Also Published As

Publication number Publication date
US5663341A (en) 1997-09-02
AU1696795A (en) 1995-08-21
EP0741712B1 (en) 2001-10-04
FI112218B (fi) 2003-11-14
AU691878B2 (en) 1998-05-28
TW472047B (en) 2002-01-11
CZ227296A3 (en) 1997-01-15
EP0741712A1 (en) 1996-11-13
ATE206407T1 (de) 2001-10-15
RO118292B1 (ro) 2003-04-30
NZ279734A (en) 1998-05-27
ES2161863T3 (es) 2001-12-16
HUT76303A (en) 1997-07-28
WO1995021162A1 (en) 1995-08-10
JPH09508628A (ja) 1997-09-02
BR9506727A (pt) 1997-09-23
UA46730C2 (uk) 2002-06-17
FI963054A0 (fi) 1996-08-01
RU2135482C1 (ru) 1999-08-27
CA2180947A1 (en) 1995-08-10
DE69523038D1 (de) 2001-11-08
DE69523038T2 (de) 2002-06-06
HU9602143D0 (en) 1996-09-30
KR100337579B1 (ko) 2002-11-13
CZ291774B6 (cs) 2003-05-14
SK281861B6 (sk) 2001-08-06
SK100696A3 (en) 1997-03-05
MX9603218A (es) 1997-07-31

Similar Documents

Publication Publication Date Title
PL291470A1 (en) Method of obtaining novel urea derivatives
DK0997459T3 (da) Mellemprodukter til fremstilling af retrovirale protease-hæmmere
KR950700253A (ko) 사람 면역결핍 바이러스 프로테아제 억제제로서의 치환된 피페콜린산 유도체(Substituted pipecolinic acid derivatives as HIV protease inhibitors)
WO1999006340A3 (en) Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
FI963054A (fi) Menetelmä HIV-proteaasi-inhibiittoreiden valmistamiseksi
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
NO931482D0 (no) Farmasoeytiske sammensetninger inneholdende quinolin- og quinazolinderivater og nye forbindelser for disse
RU92016490A (ru) Новые 2-сахаринилметил(арил и арокси)ацетаты, применимые в качестве ингибиторов протеолитических ферментов, их композиции и способ их применения
DZ1724A1 (fr) Nouvelles azétidinones substituées comme agents anti-inflammatoires et anti-dégénérescence.
FI960184A (fi) Menetelmä HIV-proteaasi-inhibiittoreiden valmistamiseksi
DE69432176T2 (de) Verfahren zur herstellung von hiv protease inhibitoren
BG105825A (en) Process for preparing alendronic acid
ES2147499A1 (es) Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos.
EP0369743A3 (en) Heterocyclic amides
ATE259785T1 (de) Verfahren zur herstellung von 2-alkylthio- substituierten benzoesäurederivaten
FI944967A (fi) Menetelmiä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten ja niiden välituotteiden valmistamiseksi
TH14727EX (th) ซับสทิทิวเต็ดอะเซ็ททิดิโนนชนิดใหม่ที่เป็นสารต้านการอักเสบและสารต้านการเสื่อมโทรม